Deep Track Capital as of June 30, 2023
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 55 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.2 | $155M | 1.3M | 123.97 | |
| Insmed Com Par $.01 (INSM) | 6.3 | $137M | 6.5M | 21.10 | |
| Ionis Pharmaceuticals (IONS) | 5.4 | $116M | 2.8M | 41.03 | |
| Travere Therapeutics (TVTX) | 5.2 | $113M | 7.4M | 15.36 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 5.1 | $110M | 2.6M | 41.57 | |
| Immunovant (IMVT) | 4.8 | $103M | 5.4M | 18.97 | |
| Intra Cellular Therapies (ITCI) | 4.5 | $98M | 1.5M | 63.32 | |
| Alkermes SHS (ALKS) | 4.3 | $94M | 3.0M | 31.30 | |
| Springworks Therapeutics (SWTX) | 4.3 | $93M | 3.5M | 26.22 | |
| Dynavax Technologies Corp Com New (DVAX) | 3.9 | $85M | 6.6M | 12.92 | |
| Geron Corporation (GERN) | 3.6 | $78M | 24M | 3.21 | |
| Pliant Therapeutics (PLRX) | 3.4 | $73M | 4.1M | 18.12 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.3 | $72M | 2.8M | 25.52 | |
| Verona Pharma Sponsored Ads (VRNA) | 3.1 | $67M | 3.2M | 21.14 | |
| Guardant Health (GH) | 2.5 | $54M | 1.5M | 35.80 | |
| 4d Molecular Therapeutics In (FDMT) | 2.3 | $50M | 2.8M | 18.07 | |
| Agenus Com New | 2.2 | $48M | 30M | 1.60 | |
| Beam Therapeutics (BEAM) | 1.9 | $42M | 1.3M | 31.93 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.7 | $36M | 15M | 2.38 | |
| Intellia Therapeutics (NTLA) | 1.6 | $34M | 835k | 40.78 | |
| Miragen Therapeutics (VRDN) | 1.4 | $30M | 1.3M | 23.79 | |
| Nurix Therapeutics (NRIX) | 1.4 | $30M | 3.0M | 9.99 | |
| Repare Therapeutics Ord (RPTX) | 1.3 | $29M | 2.7M | 10.58 | |
| Editas Medicine (EDIT) | 1.3 | $28M | 3.5M | 8.23 | |
| Dyne Therapeutics (DYN) | 1.3 | $28M | 2.5M | 11.25 | |
| Biosante Pharmaceuticals (ANIP) | 1.3 | $28M | 514k | 53.83 | |
| Axsome Therapeutics (AXSM) | 1.3 | $28M | 384k | 71.86 | |
| Point Biopharma Global | 1.2 | $25M | 2.8M | 9.06 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $21M | 2.8M | 7.75 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.0 | $21M | 2.5M | 8.20 | |
| Pacific Biosciences of California (PACB) | 0.9 | $19M | 1.5M | 13.30 | |
| Acumen Pharmaceuticals (ABOS) | 0.9 | $19M | 3.9M | 4.81 | |
| Rapt Therapeutics (RAPT) | 0.9 | $19M | 1.0M | 18.70 | |
| Prothena Corp SHS Put Option (PRTA) | 0.8 | $17M | 250k | 68.28 | |
| Vigil Neuroscience (VIGL) | 0.8 | $17M | 1.8M | 9.40 | |
| Astria Therapeutics (ATXS) | 0.7 | $14M | 1.7M | 8.33 | |
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $14M | 7.7M | 1.80 | |
| Morphic Hldg (MORF) | 0.6 | $12M | 217k | 57.33 | |
| Silence Therapeutics Ads (SLN) | 0.5 | $11M | 2.0M | 5.50 | |
| Orchard Therapeutics Spon Ads New | 0.5 | $11M | 2.0M | 5.21 | |
| Nektar Therapeutics (NKTR) | 0.5 | $10M | 18M | 0.58 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $9.6M | 1.1M | 8.75 | |
| 89bio (ETNB) | 0.4 | $9.5M | 503k | 18.95 | |
| Inozyme Pharma (INZY) | 0.4 | $9.2M | 1.6M | 5.57 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.4 | $8.5M | 300k | 28.21 | |
| Relmada Therapeutics (RLMD) | 0.3 | $7.0M | 2.8M | 2.46 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $5.9M | 499k | 11.87 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $5.6M | 678k | 8.28 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.3 | $5.5M | 109k | 51.00 | |
| Century Therapeutics (IPSC) | 0.1 | $3.2M | 1.0M | 3.16 | |
| Heron Therapeutics (HRTX) | 0.1 | $2.4M | 2.1M | 1.16 | |
| Fibrogen Call Option (FGEN) | 0.1 | $2.1M | 765k | 2.70 | |
| Allakos (ALLK) | 0.0 | $995k | 228k | 4.36 | |
| Immunic (IMUX) | 0.0 | $774k | 308k | 2.51 | |
| Mink Therapeutics (INKT) | 0.0 | $682k | 325k | 2.10 |
